Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 4,729 | 4,764 | 4,419 | 4,877 | 3,870 |
| Cost of Goods | 1,968 | 1,849 | 1,624 | 1,723 | 1,395 |
| Gross Profit | 2,761 | 2,915 | 2,795 | 3,154 | 2,475 |
| Operating Expenses | 3,711 | 3,450 | 3,171 | 3,311 | 2,553 |
| Operating Income | 18 | 314 | 248 | 566 | 317 |
| Interest Expense | 0 | 0 | 1 | 0 | 0 |
| Other Income | 44 | 26 | -1 | -8 | 47 |
| Pre-tax Income | 62 | 340 | 246 | 558 | 364 |
| Income Tax | N/A | 3 | 9 | N/A | N/A |
| Net Income Continuous | 62 | 337 | 237 | 558 | 349 |
| Net Income | $62 | $337 | $237 | $558 | $349 |
| EPS Basic Total Ops | 0.01 | 0.03 | 0.02 | 0.05 | 0.04 |
| EPS Basic Continuous Ops | 0.01 | 0.03 | 0.02 | 0.05 | 0.03 |
| EPS Diluted Total Ops | 0.01 | 0.03 | 0.02 | 0.05 | 0.04 |
| EPS Diluted Continuous Ops | 0.00 | 0.03 | 0.02 | 0.05 | 0.03 |
| EPS Diluted Before Non-Recurring Items | 0.01 | 0.03 | 0.02 | 0.05 | 0.03 |
| EBITDA(a) | $50 | $348 | $281 | $606 | $352 |